An EEG Finger-Print of fMRI deep regional activation

​

/ Meir-Hasson Y, Kinreich S, Podlipsky I, Hendler T, Intrator N.
Neuroimage. 2014 Nov 15;102 Pt 1:128-141.

 

Introducing the EEG finger-print (EFP); a computational model that tracks the activity of deep brain regions via EEG, thereby reducing the need for fMRI scanning. 

Traditional EEG neurofeedback paradigms, such as alpha/theta sampling, provide low spatial accuracy, which makes deep brain regions, such as the amygdala, largely inaccessible. The EFP model was developed in order to overcome this limitation, by using simultaneous EEG-fMRI recordings. It exploits the high spatial resolution imaging enabled by fMRI, and incorporates advanced signal processing and machine learning methods of EEG signals. Thereby, the model learns to predict a brain region’s activity as measured with the fMRI, based on the signals recorded in EEG.

 

An amygdala-EFP model successfully predicted the amygdala’s fMRI signal from a single EEG electrode. Moreover, it provided better prediction of amygdala activity than the traditional alpha/theta EEG sampling. Thus, the EFP is proposed as a more targeted biomarker of neural activity, which can be applied in EEG-based neurofeedback and other brain-guided procedures. 

​

To read the full article in NeuroImage -https://www.sciencedirect.com/science/article/abs/pii/S1053811913010963?via%3Dihub

FAQ
 

1. What is the “EEG Finger-Print” (EFP) model and why was it developed?
The EFP model is a computational approach designed to go beyond the limitations of fMRI using only EEG to measure activity of deep brain regions (e.g., the amygdala). The model used simultaneous EEG-fMRI recordings: by correlating EEG signals to fMRI-measured regional activation.  For psychiatrists, this means that the fMRI-informed biomarker can be easily integrated in clinical practice and treatment.
 

2. How was the EFP model validated in the study cited?
The article reports that the amygdala-EFP model successfully predicted the amygdala’s fMRI signal from a single EEG electrode. Importantly, the authors found that the EFP provided better prediction of amygdala activity than conventional alpha/theta EEG sampling methods.
Thus, for clinical translation, this suggests the potential to monitor amygdala activation (which is relevant in many psychiatric disorders) via EEG using the amygdala EFP.

 

3. What are the implications of applying the EFP model in neurofeedback or other brain-guided procedures?
The EFP provides a targeted biomarker of specific deep-region neural activity (as opposed to broad EEG bands), to enhance neurofeedback training. For psychiatrists, this means potential for more precise neuromodulation interventions by tracking brain region-specific activity rather than generalized signals, potentially enhancing treatment specificity for disorders involving the amygdala.

 

4. What are the key advantages of the EFP over traditional EEG neurofeedback paradigms?

• This is the first digital brain biomarker for mental health. The EFP is cutting-edge technology that removes the need for patients to get an fMRI scan to measure activity in specific brain regions, such as the amygdala. EEG is less expensive and scalable for self-modulation in psychiatry clinics. 

• Specificity for deep brain regions: The EFP was developed by applying machine learning models to register fMRI voxel data from the amygdala to EEG.

• For clinical practice. The EFP can easily be incorporated into clinical practice to measure amygdala activity based on real-time EEG. 

 

5. How might the EFP approach influence future research or clinical practice in psychiatry?
According to the article, this approach may have practical implementations in neuroscience as well as medicine for brain guided monitoring, diagnosis and intervention. Improving the spatial resolution of the EEG, may result in obtaining sufficient information on sub-cortical regions using EEG only, to better understand neural mechanisms of critical behavioral control mechanism such as emotion regulation, learning acquisition and action planning. 

 

The EFP opens the door to:

• More accessible biomarkers for deep brain activation (without needing fMRI).
   

• Enhanced neurofeedback or neuromodulation protocols that target specific brain regions.
   

• The EFP may offer a bridge between advanced neuroimaging and routine clinical application.